The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer
- 1 June 2020
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 37 (6) , 738-741
Abstract
No abstract availableKeywords
Funding Information
- Dana-Farber Cancer Institute
This publication has 14 references indexed in Scilit:
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in ChinaThe Lancet Oncology, 2020
- Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injuryThe Lancet, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Infectious complications and NK cell depletion following daratumumab treatment of Multiple MyelomaPLOS ONE, 2019
- Time to Surgery and Breast Cancer Survival in the United StatesJAMA Oncology, 2016
- Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung CancerThe Annals of Thoracic Surgery, 2015
- Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal CancerJAMA, 2011
- Lung infections after cancer chemotherapyThe Lancet Oncology, 2008